AOD-9604
AOD9604 · hGH 176-191
A synthetic peptide corresponding to the C-terminal fragment of human growth hormone (residues 176-191), studied for lipolysis and fat metabolism without the glucose or IGF-1 effects of full-length growth hormone.
Half-life
Not well characterized in humans; reported short (minutes to ~1 h). Half-life is an educational pharmacology figure, drawn from public sources, and is not a schedule or dosing instruction.
Storage & handling
Supplied lyophilized; store cool, reconstitute before use, then refrigerate and protect from light.
References
- Metabolic Pharmaceuticals phase 2 obesity program
- Peer-reviewed hGH 176-191 characterization
Related in GLP-1 / Metabolic
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.